Smoking and Drugs

  • Fran BredinEmail author


Cigarette smoking, both active and passive, has vastly contrasting effects on the development and progression of both Crohn’s disease (CD) and ulcerative colitis (UC). Quitting smoking also affects both forms of IBD differently. As smoking is a modifiable lifestyle factor, knowledge of its effects in IBD is therefore very important for those who care for people with IBD.

The use of recreational or non-prescribed drugs in IBD has not been widely investigated. There is some conflicting evidence as to the benefit of cannabis. Issues of legality leave this a poorly reported area.


Smoking Smoking cessation Cannabis 


  1. Ahmed W, Katz S (2016) Therapeutic use of cannabis in inflammatory bowel disease. Gastroenterol Hepatol 12(11):668–679Google Scholar
  2. Aldhous MC, Drummond HE, Anderson N, Baneshi MR, Smith LA, Arnott ID et al (2007) Smoking habit and load influence age at diagnosis and disease extent in ulcerative colitis. Am J Gastroenterol 102(3):589–597CrossRefGoogle Scholar
  3. Bredin F, Goodwin T, Parkes M (2011) A Crohn’s smoking cessation programme—initial results. In: ECCO congress nurses poster N006. Accessed 14 Apr 2017
  4. Calabrese E, Yanai H, Shuster D, Rubin DT, Hanauer SB (2012) Low-dose smoking resumption in ex-smokers with refractory ulcerative colitis. J Crohns Colitis 6:756–762CrossRefGoogle Scholar
  5. Challis S, Surgenor S (2004) Helping patients with Crohn’s disease to stop smoking. Prof Nurse 19(7):386–389PubMedGoogle Scholar
  6. Cosnes J, Beaugerie L, Carbonnel F, Gendre J-P (2001) Smoking cessation and the course of Crohn’s disease: an intervention study. Gastroenterology 120:1093–1099CrossRefGoogle Scholar
  7. Coward S, Heitman SJ, Clement F, Negron M, Pannacione R, Ghosh S et al (2014) Funding a smoking cessation program for Crohn’s disease: an economic evaluation. Am J Gastroenterol 110:368–377CrossRefGoogle Scholar
  8. Fernandez A, Barreiro-de Acosta M, Vallejo N, Iglesias M, Carmona A, González-Portela C et al (2012) Complementary and alternative medicine in inflammatory bowel disease patients: frequency and risk factors. Dig Liver Dis 44(11):904–908CrossRefGoogle Scholar
  9. Forbes A, Britton TC, House IM, Gazzard BG (1989) Safety and efficacy of acetarsol suppositories in unresponsive proctitis. Aliment Pharmacol Ther 3(6):553–556CrossRefGoogle Scholar
  10. Harries AD, Baird A, Rhodes J (1982) Non-smoking: a feature of ulcerative colitis. Br Med J (Clin Res Ed) 284:706CrossRefGoogle Scholar
  11. Hartmann-Boyce J, McRobbie H, Bullen C, Begh R, Stead LF, Hajek P (2016) Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev:CD010216. Accessed 15 Mar 2017
  12. Hilsden RJ, Verhoef MJ, Rasmussen H, Porcino A, DeBruyn JCC (2011) Use of complementary and alternative medicine by patients with inflammatory bowel disease. Inflamm Bowel Dis 17(2):655–662CrossRefGoogle Scholar
  13. Hoei O, Wolters F, Riis L, Aamodt G, Solberg C, Bernklev T et al (2007) Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort. Am J Gastroenterol 102(8):1692–1701CrossRefGoogle Scholar
  14. Kenelly RP, Subramaniam T, Egan LJ, Joyce MR (2013) Smoking and Crohn’s disease: active modification of an independent risk factor (Education alone is not enough). J Crohns Colitis 7:631–635CrossRefGoogle Scholar
  15. Lakatos PL, Vegh Z, Lovasz BD, David G, Pandur T, Erdelyi Z et al (2013) Is current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohort. Inflamm Bowel Dis 19(5):1010–1017CrossRefGoogle Scholar
  16. Lal S, Prasad N, Ryan M, Tangri S, Silverberg MS et al (2011) Cannabis use amongst patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 23:891–896CrossRefGoogle Scholar
  17. Lawrence IC, Murray K, Batman B, Gearry RB, Grafton R, Krishnaprasad K et al (2013) Crohn’s disease and smoking: is it ever too late to quit? J Crohns Colitis 7:e665–e671CrossRefGoogle Scholar
  18. Loftus EV, Sandborn WJ, Tremaine WJ, Mahoney DW, Zinsmeister AR, Offord KP et al (1996) Primary sclerosing cholangitis is associated with non-smoking: a case-control study. Gastroenterology 110(5):1496–1502CrossRefGoogle Scholar
  19. Lunney PC, Leong RWL (2012) Review article: ulcerative colitis, smoking and nicotine therapy. Aliment Pharmacol Ther 36:997–1008CrossRefGoogle Scholar
  20. Lunney PC, Kariyawasam VC, Wang RR, Middleton KL, Huang T, Selinger CP et al (2015) Smoking prevalence and its influence on disease course and surgery in Crohn’s disease and ulcerative colitis. Aliment Pharmacol Ther 42:61–70CrossRefGoogle Scholar
  21. Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S (2006) Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc 81(11):1462–1471CrossRefGoogle Scholar
  22. Mahid SS, Minor KS, Stromberg AJ, Galandiuk S (2007) Active and passive smoking in childhood IS related to the development of inflammatory bowel disease. Inflamm Bowel Dis 13(4):431–438CrossRefGoogle Scholar
  23. McGrath J, McDonald JW, Macdonald JK (2004) Transdermal nicotine for induction of remission in ulcerative colitis. Cochrane Database Syst Rev:CD004722. Accessed 15 Mar 2017
  24. Mokbel M, Carbonnel F, Beaugerie L, Gendre JP, Cosnes J (1998) Effect of smoking on the long-term course of ulcerative colitis. Gastroenterol Clin Biol 22(11):858–862PubMedGoogle Scholar
  25. Nunes T, Etchevers MJ, Merino O, Gallego S, García-Sánchez V, Marin-Jiménez I et al (2013a) Does smoking influence Crohn’s disease in the biologic era? The TABACROHN study. Inflamm Bowel Dis 19(1):23–29CrossRefGoogle Scholar
  26. Nunes T, Etchevers MJ, Merino O, Gallego S, García-Sánchez V, Marín-Jiménez I et al (2013b) High smoking cessation rate in Crohn’s disease patients after physician advice—the TABACROHN study. J Crohns Colitis 7:202–207CrossRefGoogle Scholar
  27. Nunes T, Etchevers MJ, Garcia-Sánchez V, Ginard D, Martí E, Barreiro-de Acosta M et al (2016) Impact of smoking cessation on the clinical course of Crohn’s disease under current therapeutic algorithms: a multicenter prospective study. Am J Gastroenterol 111(3):411–419CrossRefGoogle Scholar
  28. Parkes GC, Whelan K, Lindsay JO (2014) Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect. J Crohns Colitis 8:717–725CrossRefGoogle Scholar
  29. Roberts H, Rai SN, Pan J, Rao JM, Keskey RC, Kanaan Z et al (2014) Extraintestinal manifestations of inflammatory bowel disease and the influence of smoking. Digestion 90:122–129CrossRefGoogle Scholar
  30. Russell MG, Volovics A, Schoon EJ, van Wijlick EH, Logan RF, Shivananda S, Stockbrűgger RW (1998) Inflammatory bowel disease: is there any relation between smoking status and disease presentation? Inflamm Bowel Dis 4(3):182–186CrossRefGoogle Scholar
  31. Ryan WR, Ley C, Allan RN, Keighley MR (2003) Patients with Crohn’s disease are unaware of the risks that smoking has on their disease. J Gastrointest Surg 7(5):706–711CrossRefGoogle Scholar
  32. Severs M, Mangen M-JM, van der Valk ME, Fidder HH, Dijkstra G, van der Have M et al (2017) Smoking is associated with higher disease-related costs and lower health-related quality of life in inflammatory bowel disease. J Crohns Colitis 3:342–352Google Scholar
  33. Shields PL, Low-Beer TS (1996) Patients’ awareness of adverse relation between Crohn’s disease and their smoking: questionnaire survey. BMJ 313:265CrossRefGoogle Scholar
  34. Somerville KW, Logan RF, Edmond M, Langman MJ (1984) Smoking and Crohn’s disease. Br Med J (Clin Res Ed) 289:954–956CrossRefGoogle Scholar
  35. Stead LF, Koilpillai P, Fanshawe TR, Lancaster T (2016) Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev:CD008286Google Scholar
  36. Storr M, Devlin S, Kaplan GG, Panaccione R, Andrews CN (2014) Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease progress in patients with Crohn’s disease. Inflamm Bowel Dis 20(3):472–480CrossRefGoogle Scholar
  37. van der Heide F, Dijkstra A, Weersma RK, Albersnagel FA, van der Logt EM, Faber KN et al (2009) Effects of active and passive smoking on disease course of Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis 15:1199–1207CrossRefGoogle Scholar
  38. van der Heide F, Dijkstra A, Albersnagel FA, Kleibeuker JH, Dijkstra G (2010) Active and passive smoking behaviour and cessation plans of patients with Crohn’s disease and ulcerative colitis. J Crohns Colitis 4:125–131CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.The Queen Elizabeth Hospital King’s LynnKing’s LynnUK

Personalised recommendations